Acurx Pharmaceuticals Lands Japanese Patent for Groundbreaking DNA Polymerase IIIC Inhibitors in Cancer Treatment
Acurx Pharmaceuticals‘ Ibezapolstat Advances too Phase 3 Trials After Securing Japanese Patent Table of Contents Acurx Pharmaceuticals’ Ibezapolstat Advances too Phase 3 Trials After Securing Japanese Patent Phase 2 Clinical Trial Results About Ibezapolstat and CDI About Acurx Pharmaceuticals,Inc. Revolutionary Antibiotic Breakthrough: Acutious Pharmaceuticals’ Ibezapolstat Spearheads teh Battle against Antibiotic Resistance The Turning Point in … Read more
